Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19 (2021)
Fonte: Hematology, Transfusion and Cell Therapy. Unidades: FMRP, FM
Assuntos: COVID-19, PLASMA, TRANSFUSÃO DE SANGUE, ANTICORPOS
ABNT
DE SANTIS, Gil Cunha et al. Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19. Hematology, Transfusion and Cell Therapy, v. 43, n. 2, p. 212-213, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2021.03.001. Acesso em: 02 dez. 2025.APA
De Santis, G. C., Mendrone, A., Langhi, D., Covas, D. T., Fabron, A., Cortez, A. J. P., et al. (2021). Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19. Hematology, Transfusion and Cell Therapy, 43( 2), 212-213. doi:10.1016/j.htct.2021.03.001NLM
De Santis GC, Mendrone A, Langhi D, Covas DT, Fabron A, Cortez AJP, Dinardo CL, Ubiali EMA, Marques JFC, Bordin JO, Rugani MA. Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19 [Internet]. Hematology, Transfusion and Cell Therapy. 2021 ; 43( 2): 212-213.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1016/j.htct.2021.03.001Vancouver
De Santis GC, Mendrone A, Langhi D, Covas DT, Fabron A, Cortez AJP, Dinardo CL, Ubiali EMA, Marques JFC, Bordin JO, Rugani MA. Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19 [Internet]. Hematology, Transfusion and Cell Therapy. 2021 ; 43( 2): 212-213.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1016/j.htct.2021.03.001
